These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14756475)

  • 1. The management of local reactions due to allergen immunotherapy.
    Taşkapan O
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):94. PubMed ID: 14756475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adverse effects monitoring in allergen specific immunotherapy].
    Mosbech HF
    Ugeskr Laeger; 2006 Mar; 168(11):1105. PubMed ID: 16545211
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of an unusual cluster of systemic reactions to subcutaneous specific immunotherapy with respiratory allergens in one allergy center.
    Scherer K; Schindler C; Arnold A; Bach S; Bircher AJ
    Int Arch Allergy Immunol; 2012; 157(3):318-20. PubMed ID: 22056648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of allergen vaccines.
    Gupta P; Grammer LC
    Clin Allergy Immunol; 2004; 18():481-93. PubMed ID: 15042930
    [No Abstract]   [Full Text] [Related]  

  • 5. [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases].
    Malling HJ
    Wien Med Wochenschr; 1999; 149(14-15):410-4. PubMed ID: 10584284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.
    Bukantz SC; Lockey RF
    Clin Allergy Immunol; 2004; 18():711-27. PubMed ID: 15042944
    [No Abstract]   [Full Text] [Related]  

  • 7. Side-effects of allergen-specific immunotherapy: a prospective multi-centre study.
    Winther L; Arnved J; Malling HJ; Nolte H; Mosbech H
    Clin Exp Allergy; 2006 Mar; 36(3):254-60. PubMed ID: 16499635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralymphatic immunotherapy.
    Senti G; Johansen P; Kündig TM
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):537-43. PubMed ID: 19680119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local reactions from subcutaneous allergen immunotherapy.
    Coop CA
    Immunotherapy; 2013 Dec; 5(12):1339-45. PubMed ID: 24283844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse reactions to immunotherapy in pediatric patients].
    Avila Castañón L; Lerma-Ortiz L; Velázquez Armenta Y; del Rio Navarro BE; Sienra Monge JJ
    Rev Alerg Mex; 2003; 50(5):182-6. PubMed ID: 14631589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specific desensitization].
    Vervloet D; Charpin J
    Rev Prat; 1982 Apr; 32(23):1577-8 passim. PubMed ID: 7089464
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibilities and limitations of desensitization].
    Wenz W
    Z Gesamte Inn Med; 1980 Jan; 35(2):91-8. PubMed ID: 6996356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The history of sublingual immunotherapy.
    Pajno GB; Barberi S
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):1-3. PubMed ID: 19944001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological responses to allergen immunotherapy.
    Till SJ; Durham SR
    Clin Allergy Immunol; 2004; 18():85-104. PubMed ID: 15042910
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanisms of the effect of specific immunotherapy (hyposensitization) in atopic diseases].
    Fassakhov RS; Polsacheva OV; Zebrev AI; Rakhmatullin IM
    Patol Fiziol Eksp Ter; 1986; (4):66-9. PubMed ID: 3540819
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evolution of in vivo and in vitro tests during specific immunotherapy against hymenoptera venoms].
    Sabbah A; Heulin MG; Soulière I
    Allerg Immunol (Paris); 1990 Jun; 22(6):242-7. PubMed ID: 1696102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus.
    Tabar AI; Echechipía S; García BE; Olaguibel JM; Lizaso MT; Gómez B; Aldunate MT; Martin S; Marcotegui F
    J Allergy Clin Immunol; 2005 Jul; 116(1):109-18. PubMed ID: 15990782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic emergencies in the physician's office.
    Greenberger PA
    Clin Rev Allergy Immunol; 1999; 17(4):401-12. PubMed ID: 10829810
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthetic and genetically engineered allergen derivatives for specific immunotherapy of type I allergy.
    Valenta R; Vrtala S; Focke-Tejkl M; Twardosz A; Swoboda I; Bugajska-Schretter A; Spitzauer S; Kraft D
    Clin Allergy Immunol; 2002; 16():495-517. PubMed ID: 11577556
    [No Abstract]   [Full Text] [Related]  

  • 20. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System.
    Cox L; Larenas-Linnemann D; Lockey RF; Passalacqua G
    J Allergy Clin Immunol; 2010 Mar; 125(3):569-74, 574.e1-574.e7. PubMed ID: 20144472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.